ACHE and early-onset autosomal dominant Alzheimer disease: AChE is the key enzyme for the termination of neurotransmission in cholinergic pathways, and AChE inhibition is an effective approach for the symptomatic treatment for Alzheimer’s disease (AD) [3,4].